Table 1.
No. | Compounda | Abbreviation | Amount in 4-HMO (g/100 g blend) | Amount in 25-HMO (g/100 g blend) |
---|---|---|---|---|
1 | 2′Fucosyllactose | 2′FL | 61.9 | 18.7 |
2 | Lacto-N-neo-tetraose | LNnT | 10.3 | 7.9 |
3 | Lacto-N-tetraose | LNT | 14.4 | 7.9 |
4 | 6′Sialyllactose | 6′SL | 10.3 | 3.6 |
5 | 3-Fucosyllactose | 3-FL | – | 12.1 |
6 | Difucosyllactose | DF-L | – | 2.7 |
7 | Lacto-N-fucopentaose I | LNFP I | – | 6.5 |
8 | Lacto-N-fucopentaose II | LNFP II | – | 2.7 |
9 | Lacto-N-fucopentaose III | LNFP III | – | 1.8 |
10 | Sialyllacto-N-tetraose a | LST a | – | 0.9 |
11 | Sialyllacto-N-neo-tetraose c | LST c | – | 2.7 |
12 | 3′Sialyllactose | 3′SL | – | 3.7 |
13 | Disialyllacto-N-tetraose | DSLNT | – | 7.0 |
14–32 | Other oligosaccharidesb | – | 3.1 | 8.6 |
Others (mainly salt) | – | 2.9 | ||
TOTAL | 100.0 | 100.0 |
The abundances of each HMO are presented as a relative amount of the total measured area under the curve as determined by High Performance Anion Exchange Chromatography with Pulsed Amperometric Detection (HPAEC-PAD) for each HMO.
Compounds 1–13 (90% of all oligosaccharides in the 25-HMO blend).
Compounds 14–32 (not quantified).